Skip to content
Home » Explore » REVISIO Co., Ltd. Maximize the unique reach of spot commercials! Launch of “Spot A-UR Simulator” that reco mmends optimal budget allocation

REVISIO Co., Ltd. Maximize the unique reach of spot commercials! Launch of “Spot A-UR Simulator” that reco mmends optimal budget allocation

REVISIO Co., Ltd.
Maximize the unique reach of spot commercials! Launch of “Spot A-UR Simulator” that recommends optimal budget allocation
……
Starting Friday, December 1, 2023, REVISIO will launch a new product “Spot A-UR” that presents budget allocation to maximize *attention unique reach (A-UR) in TV commercials for spots in the Kanto and Kansai areas. We would like to inform you that we will start offering “Spot AUR Simulator” (pronunciation: Spot AUR Simulator).
REVISIO Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yasushi Koriya, hereinafter referred to as REVISIO) installs equipment equipped with human body recognition technology in homes and measures “gazing” on TV screens. Starting Friday, December 1, 2019, the new product “Spot A-UR Simulator” (read: We would like to inform you that we will start offering Spot AUR Simulator).
*Attention unique reach: Percentage of people who came into contact with the company at least once (= faced the TV screen) when the company aired a commercial.
■Background and purpose of “Spot A-UR Simulator” development *The actual GRP (total viewer ratings obtained) is decreasing year by year, making it difficult to achieve. Meanwhile, many advertisers and advertising companies have been saying that they want to eliminate unnecessary TV commercials and properly deliver TV commercials to their targets.
In order to solve this problem, we have already started offering Attention Unique Reach to some advertisers and advertising companies, and they are mainly using it to verify the effectiveness of TV commercials after they are placed. We were able to perform a correlation analysis showing that by increasing the unique reach of attention, the visibility of TV commercials increases, and we received high praise for this. We have received requests from our advertisers and advertising companies to utilize the data not only to verify effectiveness after TV commercials are placed, but also for planning before TV commercials are placed. We have developed a tool called “Spot A-UR Simulator” that can simulate the optimal budget allocation. *Actual GRP: Total viewer ratings obtained
■Features of “Spot A-UR Simulator”
・It is possible to understand the optimal budget allocation to maximize unique reach.
By entering your target, campaign budget, par cost, and design, you will find the optimal budget allocation to maximize unique reach. ・Possible to simulate gaze unique reach and gaze frequency
In addition to calculating optimal budget allocation, you can also calculate changes in reach and frequency when changing campaign budget, station share, and per cost. By operating the intuitive UI, operators can easily run multiple simulation patterns by themselves. [Image

https://revisio.co.jp/case/tkkC4_p1
[About REVISIO Co., Ltd.] REVISIO Co., Ltd. has changed its company name from TVISION INSIGHTS Co., Ltd. from October 1, 2022. We use human body recognition technology to obtain viewing behavior data for TV programs and commercials, and provide viewing analysis services for BtoB. A research device equipped with REVISIO’s proprietary human body recognition technology is installed on your home TV, and the viewing habits of survey participants are automatically acquired every second. REVISIO’s unique gaze data, which determines who is in front of the TV and who is watching properly, is used by more than 200 clients in Japan, including advertisers, advertising companies, and broadcast stations. Currently, in Japan, we provide viewing data for all terrestrial/MX/BS programs as well as connected TV viewing data for 2,000 households in the Kanto area and 600 households in the Kansai area.




Leave a Reply

This article was partly generated by AI. Some links may contain Ads. Press Release-Informed Article.